Amanda K. Ombrello

Amanda K. Ombrello

Auto-generated profile, based on publicly available information

Amanda K. Ombrello

National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2014 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
QZQing Zhou
Qing Zhou
DYDan Yang
Dan Yang
AOAmanda K. Ombrello
Amanda K. Ombrello
AZAndrey V. Zavialov
Andrey V. Zavialov
CTCamilo Toro
Camilo Toro
IAIvona Aksentijevich
Ivona Aksentijevich
We observed a syndrome of intermittent fevers, early-onset lacunar strokes and other neurovascular manifestations, livedoid rash, hepatosplenomegaly, and systemic vasculopathy in three unrelated patients. We suspected a genetic cause because the disorder presented in early childhood. We performed whole-exome sequencing in the initial three patients and their unaffected parents and candidate-gene sequencing in three patients with a similar phenotype, as well as two young siblings with polyarteritis nodosa and one patient with small-vessel vasculitis. Enzyme assays, immunoblotting, immunohistochemical testing, flow cytometry, and cytokine profiling were performed on samples from the patients. To study protein function, we used morpholino-mediated knockdowns in zebrafish and short hairpin RNA knockdowns in U937 cells cultured with human dermal endothelial cells. All nine patients carried recessively inherited mutations in CECR1 (cat eye syndrome chromosome region, candidate 1), encoding adenosine deaminase 2 (ADA2), that were predicted to be deleterious; these mutations were rare or absent in healthy controls. Six patients were compound heterozygous for eight CECR1 mutations, whereas the three patients with polyarteritis nodosa or small-vessel vasculitis were homozygous for the p.Gly47Arg mutation. Patients had a marked reduction in the levels of ADA2 and ADA2-specific enzyme activity in the blood. Skin, liver, and brain biopsies revealed vasculopathic changes characterized by compromised endothelial integrity, endothelial cellular activation, and inflammation. Knockdown of a zebrafish ADA2 homologue caused intracranial hemorrhages and neutropenia — phenotypes that were prevented by coinjection with nonmutated (but not with mutated) human CECR1. Monocytes from patients induced damage in cocultured endothelial-cell layers. Loss-of-function mutations in CECR1 were associated with a spectrum of vascular and inflammatory phenotypes, ranging from early-onset recurrent stroke to systemic vasculopathy or vasculitis. (Funded by the National Institutes of Health Intramural Research Programs and others.)

7 December 2015 in Nature Genetics
Verified
Journal Article
Open access
PDF file
QZQing Zhou
Qing Zhou
HWHongying Wang
Hongying Wang
DSDaniella M Schwartz
Daniella M Schwartz
MSMonique Stoffels
Monique Stoffels
YPYong Hwan Park
Yong Hwan Park
IAIvona Aksentijevich
Ivona Aksentijevich
Ivona Aksentijevich and colleagues identify heterozygous loss-of-function mutations in TNFAIP3 (encoding A20) in six unrelated families with early-onset systemic inflammation. Affected individuals exhibit increased expression of NF-κB–mediated proinflammatory cytokines, consistent with the established role of A20 as a potent inhibitor of the NF-κB signaling pathway. Systemic autoinflammatory diseases are driven by abnormal activation of innate immunity1. Herein we describe a new disease caused by high-penetrance heterozygous germline mutations in TNFAIP3, which encodes the NF-κB regulatory protein A20, in six unrelated families with early-onset systemic inflammation. The disorder resembles Behçet's disease, which is typically considered a polygenic disorder with onset in early adulthood2. A20 is a potent inhibitor of the NF-κB signaling pathway3. Mutant, truncated A20 proteins are likely to act through haploinsufficiency because they do not exert a dominant-negative effect in overexpression experiments. Patient-derived cells show increased degradation of IκBα and nuclear translocation of the NF-κB p65 subunit together with increased expression of NF-κB–mediated proinflammatory cytokines. A20 restricts NF-κB signals via its deubiquitinase activity. In cells expressing mutant A20 protein, there is defective removal of Lys63-linked ubiquitin from TRAF6, NEMO and RIP1 after stimulation with tumor necrosis factor (TNF). NF-κB–dependent proinflammatory cytokines are potential therapeutic targets for the patients with this disease.

1 October 2012 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
QZQing Zhou
Qing Zhou
GLGeun-Shik Lee
Geun-Shik Lee
JBJillian Brady
Jillian Brady
SDShrimati Datta
Shrimati Datta
MKMatilda Katan
Matilda Katan
IAIvona Aksentijevich
Ivona Aksentijevich

11 December 2019 in Nature
Verified
Journal Article
Closed access
PDF file
NLNajoua Lalaoui
Najoua Lalaoui
SBSteven E. Boyden
Steven E. Boyden
HOHirotsugu Oda
Hirotsugu Oda
GWGeryl M. Wood
Geryl M. Wood
DSDeborah L. Stone
Deborah L. Stone
JSJohn Silke
John Silke

24 August 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
QZQing Zhou
Qing Zhou
XYXiaomin Yu
Xiaomin Yu
EDErkan Demirkaya
Erkan Demirkaya
NDNatalie Deuitch
Natalie Deuitch
DSDeborah Stone
Deborah Stone
IAIvona Aksentijevich
Ivona Aksentijevich
Systemic autoinflammatory diseases are caused by mutations in genes that function in innate immunity. Here, we report an autoinflammatory disease caused by loss-of-function mutations in OTULIN (FAM105B), encoding a deubiquitinase with linear linkage specificity. We identified two missense and one frameshift mutations in one Pakistani and two Turkish families with four affected patients. Patients presented with neonatal-onset fever, neutrophilic dermatitis/panniculitis, and failure to thrive, but without obvious primary immunodeficiency. HEK293 cells transfected with mutated OTULIN had decreased enzyme activity relative to cells transfected with WT OTULIN, and showed a substantial defect in the linear deubiquitination of target molecules. Stimulated patients’ fibroblasts and peripheral blood mononuclear cells showed evidence for increased signaling in the canonical NF-κB pathway and accumulated linear ubiquitin aggregates. Levels of proinflammatory cytokines were significantly increased in the supernatants of stimulated primary cells and serum samples. This discovery adds to the emerging spectrum of human diseases caused by defects in the ubiquitin pathway and suggests a role for targeted cytokine therapies. Significance We describe a human disease linked to mutations in the linear deubiquitinase (DUB) OTULIN, which functions as a Met1-specific DUB to remove linear polyubiquitin chains that are assembled by the linear ubiquitin assembly complex (LUBAC). OTULIN has a role in regulating Wnt and innate immune signaling complexes. Hydrolysis of Met1-linked ubiquitin chains attenuates inflammatory signals in the NF-κB and ASC-mediated pathways. OTULIN-deficient patients have excessive linear ubiquitination of target proteins, such as NEMO, RIPK1, TNFR1, and ASC, leading to severe inflammation. Cytokine inhibitors have been efficient in suppressing constitutive inflammation in these patients. This study, together with the identification of haploinsufficiency of A20 (HA20), suggests a category of human inflammatory diseases, diseases of dysregulated ubiquitination.

18 April 2019 in New England Journal of Medicine
Verified
Journal Article
Closed access
AOAmanda K. Ombrello
Amanda K. Ombrello
JQJing Qin
Jing Qin
PHPatrycja M. Hoffmann
Patrycja M. Hoffmann
PKParag Kumar
Parag Kumar
DSDeborah Stone
Deborah Stone
DKDaniel L. Kastner
Daniel L. Kastner
The manifestations of a deficiency of adenosine deaminase 2, a genetic disease, include early-onset lacunar stroke. In a series of 15 patients with this disorder, treatment with a TNF inhibitor resulted in a reduction from 37 strokes to no strokes during 733 patient-months.